Positive: Global Bispecific Antibodies Market projected to grow to $53.8 billion by 2033 with CAGR of 24.1%.

From GlobeNewswire: 2024-04-04 12:30:00

Custom Market Insights has published a report on the Bispecific Antibodies Market, projecting a growth from $6.2 billion in 2023 to $7.7 billion in 2024 and an expected value of $53.8 billion by 2033, with a CAGR of 24.1%. Factors driving growth include cancer immunotherapy focus, expanded applications in autoimmune diseases, and advancements in antibody engineering. Strategic collaborations and rising investments in biopharmaceuticals also contribute to market dynamics. Key players like Janssen Pharmaceutical and Genentech are making significant advancements in the field, with conditional marketing authorizations and FDA approvals for innovative medications. The report also highlights the impact of the COVID-19 pandemic on the market, including clinical trial disruptions, supply chain issues, resumed trials with modified protocols, accelerated regulatory approvals, increased investment, strategic collaborations, and increased demand for targeted therapies. The report offers detailed insights into market size, growth factors, trends, and regional analysis.



Read more at GlobeNewswire: [Latest] Global Bispecific Antibodies Market Size/Share